What question did this study set out to answer?

To evaluate the efficacy of aMMP-8 as a biomarker for monitoring treatment response in periodontal disease.

March 1, 2026Open Access

Point-of-Care Biomarker Monitoring of Treatment Efficacy: Changes in Mouthrinse Active Matrix Metalloproteinase-8 (aMMP-8) Concentrations Following Periodontal Anti-Infective Treatment.

Key Points

To evaluate the efficacy of aMMP-8 as a biomarker for monitoring treatment response in periodontal disease.
Point-of-care monitoring of aMMP-8 levels was conducted.
Baseline disease severity was assessed.
Short-term periodontal healing was evaluated post-treatment.
aMMP-8 concentrations correlate with baseline disease severity.
Significant changes in aMMP-8 levels were observed after treatment.
aMMP-8 serves as a sensitive indicator of periodontal healing.

Abstract

These findings demonstrate that aMMP-8 PoC monitoring aligns with both baseline disease severity and short-term periodontal healing. aMMP-8 provides an objective biochemical dimension to periodontal assessment, capturing active collagen degradation and serving as a sensitive and clinically meaningful indicator of treatment response.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Gieselmann et al. (Thu,) studied this question.

synapsesocial.com/papers/69a3d747ec16d51705d2dcaf https://doi.org/https://doi.org/10.1155/ijod/4285673

Bookmark

View Full Paper